TABLE 7.
In vitro endogenous HBV polymerase sensitivity to ETV-TP for patient A
Genotypea | Patient A RT substitution atb:
|
ETV IC50 (nM)c | Fold increase in IC50d | ||||
---|---|---|---|---|---|---|---|
I169 | V173 | L180 | M204 | M250 | |||
wt | — | — | — | — | — | 0.5 ± 0.1 | 1 |
Baseline (3TCr) | — | L | M | V | — | 27 ± 6 | 54 |
wk 106 | T | L | M | V | V | 240 ± 71 | 480 |
del 173L | T | — | M | V | V | 240 ± 11 | 480 |
del 169T | — | L | M | V | V | 140 ± 16.4 | 280 |
del 250 | T | L | M | V | — | 26 ± 0.4 | 52 |
del 173L, 250V | T | — | M | V | — | 32 ± 9.3 | 64 |
del 173L, 3TCr | T | — | — | — | V | 37 ± 3.7 | 74 |
wt values are for the laboratory genotype D clone pCMV-HBV 180B3. del, deletion.
—, wt residue.
Values are the mean and standard deviation from three or more independent experiments.
Fold increase in IC50 over that of the wt control.